Literature DB >> 316976

beta-Blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?

C Salazar, W Frishman, S Friedman, J Patel, Y T Lin, Y Oka, R W Frater, R M Becker.   

Abstract

A high incidence of cardiac arrhythmias and hypertension has been noted after coronary artery bypass surgery in patients previously treated with oral propranolol. Forty-two patients undergoing coronary bypass surgery had propranolol withdrawal 10 hours before surgery and were randomized into a group treated with propranolol immediately postoperatively, and a nontreatment group. Patients treated with prophylactic propranolol had a significantly lower incidence of postoperative supraventricular arrhythmias compared to patints who received no prophylaxis. All the arrhythmias responded rapidly to 1 mg of intravenous propranolol therapy, whether it was used as a primary treatment or as a supplement to prophylactic propranolol. The findings suggest that (1) there is a high incidence of supraventricular arrhythmias and sinus tachycardia after coronary artery bypass which might reflect an abrupt propranolol withdrawal, and (2) that perioperative prophylactic or supplementary propranolol therapy will successfully prevent or treat most of these arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316976     DOI: 10.1177/000331977903001204

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

1.  Polypharmacy in a general surgical unit and consequences of drug withdrawal.

Authors:  J M Kennedy; A M van Rij; G F Spears; R A Pettigrew; I G Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Risk Factors for Post-Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation and the Role of Aspirin and Beta Blockers in its Prevention.

Authors:  Muhammad F Khan; Aravind Herle; Mohammad Reza Movahed
Journal:  J Atr Fibrillation       Date:  2013-02-12

Review 3.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 4.  Perioperative beta-blockers for preventing surgery-related mortality and morbidity.

Authors:  Hermann Blessberger; Juergen Kammler; Hans Domanovits; Oliver Schlager; Brigitte Wildner; Danyel Azar; Martin Schillinger; Franz Wiesbauer; Clemens Steinwender
Journal:  Cochrane Database Syst Rev       Date:  2018-03-13

5.  Pharmacological and nonpharmacological prevention of atrial fibrillation after coronary artery bypass surgery.

Authors:  Majid Haghjoo
Journal:  J Tehran Heart Cent       Date:  2012-02-28

6.  Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery.

Authors:  Hermann Blessberger; Sharon R Lewis; Michael W Pritchard; Lizzy J Fawcett; Hans Domanovits; Oliver Schlager; Brigitte Wildner; Juergen Kammler; Clemens Steinwender
Journal:  Cochrane Database Syst Rev       Date:  2019-09-23

7.  Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery?

Authors:  Oruc Alper Onk; Bilgehan Erkut
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

Review 8.  Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management.

Authors:  Giovanni Peretto; Alessandro Durante; Luca Rosario Limite; Domenico Cianflone
Journal:  Cardiol Res Pract       Date:  2014-01-06       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.